Elysium Health is developer and manufacturer of supplements intended to improve health functions, bodily functions, DNA health, circadian rhythm, and energy creation. Currently, the group’s only product is Basis, a supplement containing two primary ingredients that boost metabolism and otherwise help its consumers live better lives.
Basis is backed by nearly three decades’ worth of research. Basis is intended to be taken daily, and typically recommended to be taken in the morning. The supplement contains nicotinamide riboside and pterostilbene. Nicotinamide riboside is a precursor to NAD+ – shorthand for nicotinamide adenine dinucleotide – a substance that naturally occurs in the human body, called a coenzyme, that is necessary for loads of regular bodily functions.
As humans age, we steadily lose our natural supply of nicotinamide adenine dinucleotide, causing the functions it fuels to slow down. Rather than surrendering to nature and foregoing the necessary supply of NAD+ that efficiently fuels our bodies, taking Basis helps promote our circadian rhythms and metabolisms.
The other ingredient found in Basis, pterostilbene, is a sirtuin activator – a proper term for a substance that helps proteins in our bodies work more effectively – that helps small organisms in our bodies last longer. Plus, these sirtuins only work when ample stores of nicotinamide adenine dinucleotide are present As such, the combination of these two ingredients help its consumers live more efficient, effective lives on a microscopic level.
Basis has been subject to a full-fledged clinical trial that few other supplements are. The clinical trial, funded by its parent company Elysium Health, found that levels of NAD+ in its subjects’ bodies had increased an average of 40 percent after roughly one month of taking Basis once each day. As long as its consumers continued to take Basis on a daily regimen, levels of nicotinamide adenine dinucleotide held constant at this level.
Consumers can purchase Basis by logging on to their official website – a simple Google search for Elysium Health and Basis should suffice – where it can be found for one-time purchases or recurring subscriptions. The most attractive deal offers Basis for 6 months at the reasonable price of $270 total. Consumers can otherwise purchase subscriptions for only $50 per month, or buy just one bottle for $60.
Rather than having to set reminders to go buy more Basis, Elysium Health automatically ships them to consumers’ homes, taking the pain out of dosing.
Elysium Health is organized by some of the world’s leading scientists, all of which practice in medicine, biochemistry, and other related fields. They take residency at some of the world’s best colleges, including Cambridge, Harvard, Stanford, and Oxford, to name a few.
Louis Chênevert has done a lot for UTC. This is because of his knowledge as well as experience. He has spent 14 years of his life at General Motors before becoming the CEO and Chairman of United Technologies Corporation. His education is from the Université de Montréal, École des Hautes études commerciales.
The career of Louis Chênevert at UTC started when he joined their Pratt & Whitney business unit. He worked for six years at Pratt & Whitney Canada and became the President of the Pratt & Whitney division in 1999. After spending seven years in this position, he was elected as the President and CEO at UTC.
Louis Chênevert has always believed in using technology for his company and investing in the employees in order to make huge improvements. This has been his driving principle in life. This has helped him to take UTC far.
UTC is known for its illustrious Employee Scholar Program. This is a program that covers the cost of education of those employees who are pursuing further studies in their respective fields. Nearly 40,000 UTC employees have been covered under this program since 1996 all across the globe. The total cost for UTC under this project has been more than $1 billion in the United States itself.
Another admirable quality of Louis Chênevert is that he is able to identify projects with high potential. In this way, he is able to inspire people with his vision. Now he has passed such guiding philosophies to Gregory Hayes, who is the current CEO of UTC. Both of them like to invest a sizable part of their budget to technological innovations that can advance their company. This reflects their vision and mission. They are well aware that the modern companies of today can succeed only through investment in the latest technology.
There is a lot that UTC has achieved. This includes the acquisition of Goodrich, besides the manufacture of another alternate engine for the US Air Force. Hence the Pratt & Whitney unit of UTC became the only supplier of the F-35 engine for the government of the US under Louis Chênevert.